Cheminformatics techniques in antimalarial drug discovery and development from natural products 2: Molecular scaffold and machine learning approaches

References

[1] World Health Organization. World malaria report 2011. Accessed at https://www.who.int/malaria/publications/atoz/9789241564403/en/ Accessed: 09 Apr 2019.Search in Google Scholar

[2] Bahia AC, Dong Y, Blumberg BJ, Mlambo G, Tripathi A, BenMarzouk-Hidalgo OJ, et al. Exploring Anopheles gut bacteria for Plasmodium blocking activity. Environ Microbiol. 2014;16:2980–94.10.1111/1462-2920.12381Search in Google Scholar

[3] Garnham PCC. Malaria parasites and other haemosporidia. Oxford: Blackwell Scientific, London, 1966.Search in Google Scholar

[4] World Malaria Report 2018. Geneva: World Health Organization, 2018. Licence: CC BY-NC-SA 3.0 IGO. Accessed at: https://apps.who.int/iris/bitstream/handle/10665/275867/9789241565653-eng.pdf?ua=1. Accessed: 09 Apr 2019.Search in Google Scholar

[5] Hviid L, Jensen ATR. PfEMP1–A parasite protein family of key importance in Plasmodium falciparum Malaria immunity and pathogenesis. Adv Parasitol. 2015;88:51–84.10.1016/bs.apar.2015.02.004Search in Google Scholar

[6] Beeson JG, Chu CS, Richards JS, Nosten F, Fowkes FJI. Plasmodium vivax Malaria: challenges in diagnosis, treatment and elimination. Pediatr Infect Dis J. 2015;34:529–31.10.1097/INF.0000000000000671Search in Google Scholar

[7] Gill CJ. Plasmodium vivax malaria in the UK. BMJ. 2015;350:h1840.10.1136/bmj.h1840Search in Google Scholar

[8] Das A. The distinctive features of Indian malaria parasites. Trends Parasitol. 2015;31:83–6.10.1016/j.pt.2015.01.006Search in Google Scholar

[9] Tomar LR, Giri S, Bauddh NK, Jhamb R. Complicated malaria: a rare presentation of Plasmodium ovale. Trop Doct. 2015;45:140–2.10.1177/0049475515571989Search in Google Scholar

[10] ElSohly HN, Croom EM, Jr, El-Feraly FS, El-Sherei MM. A large-scale extraction technique of artemisinin from Artemisia annua. J Nat Prod. 1990;53:1560–4.10.1021/np50072a026Search in Google Scholar

[11] De Vries PJ, Dien TK. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs. 1996;52:818–36.10.2165/00003495-199652060-00004Search in Google Scholar

[12] Price RN, Nosten F, Luxemburger C, Ter Kuile F, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artemisinin derivatives on malaria transmissibility. The Lancet. 1996;347:1654–8.10.1016/S0140-6736(96)91488-9Search in Google Scholar

[13] World Health Organization. Guidelines for the treatment of malaria. World Health Organization, 2006. Available at: http://archives.who.int/publications/2006/9241546948_eng.pdf. Accessed: 09 Apr 2019.Search in Google Scholar

[14] World Health Organization. Guidelines for the treatment of malaria. World Health Organization, 2015. Avialable at: https://apps.who.int/iris/bitstream/handle/10665/162441/9789241549127_eng.pdf?sequence=1. Accessed: 09 Apr 2019.Search in Google Scholar

[15] World Health Organization. Artemisinin resistance and artemisinin-based combination therapy efficacy: status report. World Health Organization, 2018. Available at: https://apps.who.int/iris/handle/10665/274362. Accessed: 09 Apr 2019.Search in Google Scholar

[16] Laurent D, Pietra F. Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria. A review. Mar Biotechnol. 2006;8:433–47.10.1007/s10126-006-6100-ySearch in Google Scholar PubMed

[17] Kaur K, Jain M, Kaur T, Jain R. Antimalarials from nature. Bioorg Med Chem. 2009;17:3229–56.10.1016/j.bmc.2009.02.050Search in Google Scholar PubMed

[18] Batista R, De Jesus Silva Júnior A, De Oliveira AB. Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products. Molecules. 2009;14:3037–72.10.3390/molecules14083037Search in Google Scholar PubMed PubMed Central

[19] Mojab F. Antimalarial natural products: a review. Avicenna J Phytomed. 2012;2:52–62.Search in Google Scholar

[20] Nondo RSO, Zofou D, Moshi MJ, Erasto P, Wanji S, Ngemenya MN, et al. Ethnobotanical survey and in vitro antiplasmodial activity of medicinal plants used to treat malaria in Kagera and Lindi regions, Tanzania. J Med Plant Res. 2015;9:179–92.10.5897/JMPR2014.5685Search in Google Scholar

[21] Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14:111–29.10.1038/nrd4510Search in Google Scholar PubMed

[22] Egieyeh S, Malan SF, Christoffels A. Cheminformatics techniques in antimalarial drug discovery and development from natural products 1. Basic concept.Phys Sci Rev. 2019. DOI: 20180130.Search in Google Scholar

[23] Hu Y, Stumpfe D, Bajorath J. Lessons learned from molecular scaffold analysis. J Chem Inf Model. 2011;51:1742–53.10.1021/ci200179ySearch in Google Scholar PubMed

[24] Yongye AB, Waddell J, Medina-Franco JL. Molecular scaffold analysis of natural products databases in the public domain. Chem Biol Drug Des. 2012;80:717–24.10.1111/cbdd.12011Search in Google Scholar PubMed

[25] Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8:531–41.10.1038/nchem.2479Search in Google Scholar PubMed

[26] Laraia L, Waldmann H. Natural product inspired compound collections: evolutionary principle, chemical synthesis, phenotypic screening, and target identification. Drug Discov Today: Technol. 2017;23:75–82.10.1016/j.ddtec.2017.03.003Search in Google Scholar PubMed

[27] Schneider P, Schneider G. Privileged structures revisited. Angew Chem Int Ed Engl. 2017;56:7971–4.10.1002/anie.201702816Search in Google Scholar PubMed PubMed Central

[28] Ertl P, Jelfs S, Mühlbacher J, Schuffenhauer A, Selzer P. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. J Med Chem. 2006;49:4568–73.10.1021/jm060217pSearch in Google Scholar PubMed

[29] Krier M, Bret G, Rognan D. Assessing the scaffold diversity of screening libraries. J Chem Inf Model. 2006;46:512–24.10.1021/ci050352vSearch in Google Scholar PubMed

[30] Lipkus AH, Yuan Q, Lucas KA, Funk SA, Bartelt III WF, Schenck RJ, et al. Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry. J Org Chem. 2008;73:4443–51.10.1021/jo8001276Search in Google Scholar PubMed

[31] Dimova D, Bajorath J. Assessing scaffold diversity of kinase inhibitors using alternative scaffold concepts and estimating the scaffold hopping potential for different kinases. Molecules. 2017;22:730.10.3390/molecules22050730Search in Google Scholar PubMed PubMed Central

[32] Laraia L, Robke L, Waldmann H. Bioactive compound collections: from design to target identification. Chem. 2018;4:705–30.10.1016/j.chempr.2018.01.012Search in Google Scholar

[33] Boufridi A, Quinn RJ. Harnessing the properties of natural products. Annu Rev Pharmacol Toxicol. 2018;58:451–70.10.1146/annurev-pharmtox-010716-105029Search in Google Scholar PubMed

[34] Bemis GW, Murcko MA. The properties of known drugs. 1. Molecular frameworks. J Med Chem. 1996;39:2887–93.10.1021/jm9602928Search in Google Scholar PubMed

[35] Egieyeh S, Syce J, Christoffels A, Malan SF. Exploration of scaffolds from natural products with antiplasmodial activities, currently registered antimalarial drugs and public malarial screen data. Molecules. 2016;21:104.10.3390/molecules21010104Search in Google Scholar PubMed PubMed Central

[36] Shang J, Sun H, Liu H, Chen F, Tian S, Pan P, et al. Comparative analyses of structural features and scaffold diversity for purchasable compound libraries. J Cheminform. 2017;9:25.10.1186/s13321-017-0212-4Search in Google Scholar PubMed PubMed Central

[37] Wetzel S, Schuffenhauer A, Roggo S, Ertl P, Waldmann H. Cheminformatic analysis of natural products and their chemical space. CHIMIA. 2007;61:355–60.10.2533/chimia.2007.355Search in Google Scholar

[38] Wetzel S, Klein K, Renner S, Rauh D, Oprea TI, Mutzel P, et al. Interactive exploration of chemical space with Scaffold Hunter. Nat Chem Biol. 2009;5:581–3.10.1038/nchembio.187Search in Google Scholar PubMed

[39] Xu Y-J, Pieters L. Recent developments in antimalarial natural products isolated from medicinal plants. Mini-Rev Med Chem. 2013;13:1056–72.10.2174/1389557511313070009Search in Google Scholar PubMed

[40] Beaufay C, Bero J, Quetin-Leclercq J. Antimalarial terpenic compounds isolated from plants used in traditional medicine [2010–July 2016]. In: Mérillon JM, Riviere C, editors. Natural antimicrobial agents. Sustainable development and biodiversity, Vol. 19. Cham: Springer, 2018:247–68.10.1007/978-3-319-67045-4_10Search in Google Scholar

[41] Mayer AMS, Rodríguez AD, Berlinck RGS, Fusetani N. Marine pharmacology in 2007–8: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous system, and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmacol. 2011;153:191–222.10.1016/j.cbpc.2010.08.008Search in Google Scholar PubMed PubMed Central

[42] Davis RA, Buchanan MS, Duffy S, Avery VM, Charman SA, Charman WN, et al. Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp. J Med Chem. 2012;55:5851–8.10.1021/jm3002795Search in Google Scholar PubMed

[43] Shao C-L, Mou X, Cao F-F, Spadafora C, Glukhov E, Gerwick L, et al. Bastimolide B, an Antimalarial 24-membered marine macrolide possessing a tert-butyl group. J Nat Prod. 2018;81:211–15.10.1021/acs.jnatprod.7b00917Search in Google Scholar PubMed

[44] Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009;37:W623–33.10.1093/nar/gkp456Search in Google Scholar PubMed PubMed Central

[45] Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P. The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One. 2013;8:e62906.10.1371/journal.pone.0062906Search in Google Scholar PubMed PubMed Central

[46] Bathurst I, Hentschel C. Medicines for Malaria Venture: sustaining antimalarial drug development. Trends Parasitol. 2006;22:301–7.10.1016/j.pt.2006.05.011Search in Google Scholar PubMed

[47] Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–30.10.1161/CIRCULATIONAHA.115.001593Search in Google Scholar PubMed PubMed Central

[48] Periwal V, Rajappan JK, Open Source Drug Discovery Consortium, Jaleel AUC, Scaria V. Predictive models for anti-tubercular molecules using machine learning on high-throughput biological screening datasets. BMC Res Notes. 2011;4:504.10.1186/1756-0500-4-504Search in Google Scholar PubMed PubMed Central

[49] Kovalishyn V, Grouleff J, Semenyuta I, Sinenko VO, Slivchuk SR, Hodyna D, et al. Rational design of isonicotinic acid hydrazide derivatives with antitubercular activity: machine learning, molecular docking, synthesis and biological testing. Chem Biol Drug Des. 2018;92:1272–8.10.1111/cbdd.13188Search in Google Scholar PubMed

[50] Jamal S, Periwal V, Open Source Drug Discovery Consortium, Scaria V. Predictive modeling of anti-malarial molecules inhibiting apicoplast formation. BMC Bioinformatics. 2013;14:55.10.1186/1471-2105-14-55Search in Google Scholar PubMed PubMed Central

[51] Egieyeh S, Syce J, Malan SF, Christoffels A. Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach. PLoS One. 2018;13:e0204644.10.1371/journal.pone.0204644Search in Google Scholar PubMed PubMed Central

[52] Kaiser TM, Burger PB, Butch CJ, Pelly SC, Liotta DC. A machine learning approach for predicting HIV reverse transcriptase mutation susceptibility of biologically active compounds. J Chem Inf Model. 2018;58:1544–52.10.1021/acs.jcim.7b00475Search in Google Scholar PubMed

[53] Ekins S, Puhl AC, Zorn KM, Lane TR, Russo DP, Klein JJ, et al. Exploiting machine learning for end-to-end drug discovery and development. Nature Mater. 2019;18:435.10.1038/s41563-019-0338-zSearch in Google Scholar PubMed PubMed Central

[54] Frederich M, Tits M, Angenot L. Potential antimalarial activity of indole alkaloids. Trans R Soc Trop Med Hyg. 2008;102:11–19.10.1016/j.trstmh.2007.10.002Search in Google Scholar PubMed

[55] Adebayo JO, Krettli AU. Potential antimalarials from Nigerian plants: a review. J Ethnopharmacol. 2011 Jan 27;133:289–302.10.1016/j.jep.2010.11.024Search in Google Scholar PubMed

[56] Hertweck C. Natural products as source of therapeutics against parasitic diseases. Angew Chem Int Ed. 2015;54:14622–4.10.1002/anie.201509828Search in Google Scholar PubMed

[57] Nogueira CR, Lopes LMX. Antiplasmodial natural products. Molecules. 2011;16:2146–90.10.3390/molecules16032146Search in Google Scholar

[58] Lawal B, Shittu OK, Kabiru AY, Jigam AA, Umar MB, Berinyuy EB, et al. Potential antimalarials from African natural products: a reviw. J Intercultural Ethnopharmacol. 2015;4:318–43.10.5455/jice.20150928102856Search in Google Scholar

[59] Gabriel HB, Sussmann RAC, Kimura EA, Rodriguez AAM, Verdaguer IB, Leite GCF, et al. Terpenes as potential antimalarial drugs. In: Perveen S, Al-Taweel A, editors. Terpenes and terpenoids. London: IntechOpen, 2018:45.Search in Google Scholar

[60] Barros RC, Basgalupp MP, Ruiz DD, de Carvalho ACPLF, Freitas AA Evolutionary model tree induction. In: Proceedings of the 2010 ACM Symposium on Applied Computing 2010;1131–7.10.1145/1774088.1774327Search in Google Scholar

[61] Chu W, Keerthi SS. Support vector ordinal regression. Neural Comput. 2007;19:792–815.10.1162/neco.2007.19.3.792Search in Google Scholar

[62] Chang -C-C, Lin C-J. LIBSVM: A library for support vector machines. Acm T Intel Syst Tec [TIST]. 2011;2:27.10.1145/1961189.1961199Search in Google Scholar

[63] Gardner M, Dorling S. Artificial neural networks [the multilayer perceptron]—a review of applications in the atmospheric sciences. Atmos Environ. 1998;32:2627–36.10.1016/S1352-2310(97)00447-0Search in Google Scholar

[64] Vianna GK, Cruz SMS. Using multilayer perceptron networks in early detection of late blight disease in tomato leaves. In: Proc. ICAI 2014;14:158–64.Search in Google Scholar

[65] Nidhi, Glick M, Davies JW, Jenkins JL. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model. 2006;46:1124–33.10.1021/ci060003gSearch in Google Scholar PubMed

[66] Zhang H, Yu P, Xiang M-L, Li X-B, Kong W-B, Ma J-Y, et al. Prediction of drug-induced eosinophilia adverse effect by using SVM and naïve Bayesian approaches. Med Biol Eng Comput. 2016;54:361–9.10.1007/s11517-015-1321-8Search in Google Scholar PubMed

[67] Sheridan RP. Three useful dimensions for domain applicability in QSAR models using random forest. J Chem Inf Model. 2012;52:814–23.10.1021/ci300004nSearch in Google Scholar PubMed

[68] Singh H, Singh S, Singla D, Agarwal SM, Raghava GP. QSAR based model for discriminating EGFR inhibitors and non-inhibitors using random forest. Biol Direct. 2015;10:10.10.1186/s13062-015-0046-9Search in Google Scholar PubMed PubMed Central

[69] Martišius I, Šidlauskas K, Damaševičius R. Real-time training of voted perceptron for classification of EEG data. Int J Artif Intell. 2013;10:41–50.Search in Google Scholar

[70] Loukeris N, Eleftheriadis I. Further higher moments in portfolio selection and a priori detection of bankruptcy, under multi-layer perceptron neural networks, hybrid neuro-genetic MLPs, and the voted perceptron. Int J Fin Econ. 2015;20:341–61.10.1002/ijfe.1521Search in Google Scholar

[71] Nguyen G, Dlugolinsky S, Bobák M, Tran V, García ÁL, Heredia I, et al. Machine learning and deep learning frameworks and libraries for large-scale data mining: a survey. Artif Intell Rev. 2019;52:1–48.10.1007/s10462-018-09679-zSearch in Google Scholar

[72] Guyon I, Elisseeff A. An introduction to variable and feature selection. J Mach Learn Res. 2003;3:1157–82.Search in Google Scholar

[73] Jiménez-Valverde A. Insights into the area under the receiver operating characteristic curve (AUC) as a discrimination measure in species distribution modelling. Global Ecol Biogeogr. 2012;21:498–507.10.1111/j.1466-8238.2011.00683.xSearch in Google Scholar

[74] Sahigara F, Mansouri K, Ballabio D, Mauri A, Consonni V, Todeschini R. Comparison of different approaches to define the applicability domain of QSAR models. Molecules. 2012;17:4791–810.10.3390/molecules17054791Search in Google Scholar PubMed PubMed Central

[75] Netzeva TI, Worth AP, Aldenberg T, Benigni R, Cronin MTD, Gramatica P, et al. Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. ATLA Altern Lab Anim. 2005;33:155–73.10.1177/026119290503300209Search in Google Scholar PubMed

[76] Jaworska J, Nikolova-Jeliazkova N, Aldenberg T. QSAR applicability domain estimation by projection of the training set in descriptor space: a review. ATLA Altern Lab Anim. 2005;33:445.10.1177/026119290503300508Search in Google Scholar PubMed

[77] Roy K, Kar S. Importance of applicability domain of QSAR models. Pharmaceutical Sciences: Breakthroughs in Research and Practice. 2017;1012–43.10.4018/978-1-5225-1762-7.ch039Search in Google Scholar

[78] Aït-Sahalia Y, Xiu D. Using principal component analysis to estimate a high dimensional factor model with high-frequency data. J Econ. 2017;201:384–99.10.1016/j.jeconom.2017.08.015Search in Google Scholar

[79] Molecular Operating Environment (MOE). Montreal. QC, Canada: Chemical Computing Group ULC, 2016.Search in Google Scholar

[80] López-López E, Naveja JJ, Medina-Franco JL. DataWarrior: an evaluation of the open-source drug discovery tool. Expert Opin Drug Discov. 2019;14:335–41.10.1080/17460441.2019.1581170Search in Google Scholar PubMed

[81] Schäfer T, Kriege N, Humbeck L, Klein K, Koch O, Mutzel P. Scaffold Hunter: a comprehensive visual analytics framework for drug discovery. J Cheminf. 2017;9:28.10.1186/s13321-017-0213-3Search in Google Scholar PubMed PubMed Central